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In addition to original articles, the Journal of Oral Biosciences
also publishes review articles by the prizewinners of the “Lion
Dental Research Award” and “Rising Members Award,” presented
by the Japanese Association for Oral Biology. The Journal also
publishes review articles featuring recent information presented
in symposia held during the annual meeting of the Association. In
2015, we published special issues featuring the following reviews:
“Novel challenge for bone formation and bone resorption,” “The
front line of research on oral microbiota,” “Clinical insight into the
study of orofacial pain,” “Carving a disease by omics,” “The front
line of bioimaging—new light shining on oral biosciences,” “Bio-
dental engineering—integration of biology and material science,”
“Translational dental research over the CCN family,” “Salivary
glands,” “Break the negative spiral consisting of periodontitis,
diabetes and Alzheimer's disease: extending healthy life expec-
tancy through oral health,” “Immunology and oncology,” “Oral
microbiome and bioﬁlm research: new concepts and new
approaches,” “Bone remodeling mechanisms of bone resorption
and bone formation,” and “The front line of oral bioﬁlm research,”
in addition to the review articles by the invited authors in the ﬁeld
of microbiology. These reviews published in the Journal of Oral
Biosciences have inspired the readers of the journal to broaden
their knowledge regarding various aspects of oral biosciences. The
current editorial review introduces these exciting review articles.2. Novel challenge for bone formation and bone resorption
It is well known that sympathetic nerve activity and hormone
serum levels show circadian rhythms, and have been identiﬁed inx.doi.org/10.1016/j.job.2015.12.001
79/& 2015 Japanese Association for Oral Biology. Published by Elsevier B.V. Allmost animals [1–3]. Although circadian rhythms are also prevalent
in bone metabolism, the underlying molecular mechanisms are
poorly understood. Recently, clock genes were discovered to be the
modulators of circadian rhythmicity in animals. In their review
article [4], Kondo and Togari focused on their recent ﬁndings
regarding the circadian regulation of bone metabolism by β-
adrenergic signaling, glucocorticoids, and clock genes [5–7]. They
demonstrated that β-adrenergic signaling and/or glucocorticoids
are mediators of circadian rhythms from the suprachiasmatic
nuclei (SCN), where the main circadian rhythm is regulated by
endogenous circadian clocks, to peripheral osteoblasts. In addition,
glucocorticoids are one of the most important factors in the
transmission of circadian timing from the SCN to peripheral
osteoclasts. Finally, the osteoclast peripheral clock may regulate
the circadian rhythm of bone resorption by regulating the
expression of osteoclast-related genes such as cathepsin K (mCtsk)
and nuclear factor of activated T-cells cytoplasmic 1 (mNfatc1) [6].
Thus, the clock gene, muscle Arnt-like protein (BMAL), contributes
to osteoclast circadian rhythm.
Regarding osteoclast differentiation from hematopoietic stem
cells, recent studies have found that two proteins, receptor acti-
vator of NF-κB (RANK) and its ligand (RANKL), are crucial for
osteoclast development [8,9]. It has been reported that mice
lacking both NF-κB1 and NF-κB2 develop typical osteopetrosis
accompanied by a dramatic reduction in osteoclast number due to
defective tracking of the osteoclast lineage [10,11], suggesting that
osteoclast differentiation depends on RANKL-induced NF-κB acti-
vation in the osteoclast precursors. A recent study reported that
in vitro inactivation of NF-κB using speciﬁc inhibitors and in vivo
expression of dominant-negative IKKβ in osteoblasts enhanced
osteoblastic bone formation [12], suggesting that NF-κB regulates
both osteoblastic bone formation and osteoclastic bone resorption.rights reserved.
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recent discoveries, highlighting the roles of the “classical” and
“alternative” NF-κB signaling pathways in bone morphogenetic
protein (BMP) induced osteoblast differentiation and bone for-
mation, and discussed the possibility that inhibition of NF-κB
might promote BMP-induced bone regeneration for the treatment
of bone diseases. Activation of the classical and alternative NF-κB
pathways negatively regulates osteoblastic bone formation by
modulating BMP/Smad signaling through two distinct mechan-
isms: inhibition of BMP-induced Smad DNA binding, and Smad1/5/
8 phosphorylation [14–16]. Speciﬁc inhibitors of the NF-κB path-
ways seem to be efﬁcient not only in preventing bone loss, but also
in stimulating bone formation, which is referred to as “One bite
provides dual tastes.” Thus, NF-κB-selective inhibitors may have
the potential to improve BMP-induced bone regeneration.3. The front line of research on oral microbiota
Anaerobic cultural methods continue to expand our under-
standing of the oral microbiota of periodontitis and dental caries,
although approaches for strain identiﬁcation have evolved from
biochemical tests to 16S rRNA sequence-based identiﬁcation.
Tanner, in her review article [17] based on her ﬁndings [18–22],
focused on selective anaerobic culture studies that have provided
the basis of our understanding of the oral microbiota. Non-cultural
molecular analyses of plaque samples, mainly based on analysis of
the 16S rRNA gene, have highlighted both the strengths and lim-
itations of the culture-based methods in describing the complete
oral microbiota. Nevertheless, when bacteria are detected by
molecular methods, the focus then becomes to devise methods to
cultivate them [23] which frequently involves the use of anaerobic
methods. Anaerobic culture of bacteria associated with advanced
periodontitis and dental caries, compared to healthy, non-dis-
eased, sites has proven extremely valuable in expanding our
knowledge of the bacteria associated with these major clinical
conditions of the oral cavity. Anaerobic culture studies have
enabled the rapid detection and identiﬁcation of species using
molecular methods that can be used in studies of larger popula-
tions of subjects. However, it can process only a limited number of
samples. Furthermore, species in lower proportions of the overall
microbiota, and species for which the nutritional requirements are
as yet unknown, remain undetected by anaerobic culture [23]. A
ﬁnding of clinical importance is that the pathogens in advanced
periodontal and carious lesions were detected in the initial stages
of the disease as well, suggesting that they can be suitable can-
didates for disease risk assessment. Since dental pathogens may
also colonize healthy sites, assessment of periodontal and caries
risk will require the addition of other risk markers—for example,
host factors in periodontitis [24], and diet in dental caries [25].
Oral malodor in humans has long been a major health concern
and may serve as a useful assessment tool for evaluating patients
in a critical condition. Epidemiological studies have found that
poor oral hygiene is associated with an increased risk of squamous
cell carcinoma of the head, neck, and esophagus [26,27]; some
have shown that the association might be causal [28–30]. Malodor
originating in the oral cavity is an indicator of the metabolic out-
put of the oral microbial communities as a whole. It is possible
that the oral malodorous gases indicate not only halitosis, but also
the pathogenicity of oral microbiota. In their review article [31],
Tanda and colleagues focused on the role of microorganisms in
producing malodorous gases, as well as the development of ana-
lytical techniques for the treatment of halitosis. Since most oral
malodor originates from microbial activities in the mouth [30],
and microbial activities cause aspiration pneumonia in hospita-
lized patients [32], oral malodor can serve as an indicator of theoral condition of critically ill patients. The oral cavity is easily
exposed to tobacco smoke and alcohol, which are not only pro-
minent risk factors for carcinogenesis, but also the strongest fac-
tors that increase microbial acetaldehyde production [33].
Hydrogen sulﬁde has been recognized as both a major cause of
halitosis and as a gaseous-signaling molecule that might modulate
cell physiology [34]. Continuous advances in the analytical tech-
niques examining oral malodorous gases for the treatment of
halitosis would enable better risk assessment of aspiration pneu-
monia and oral cancer in the future. Furthermore, metabolic
approaches to oral malodor [35] may also elucidate the mechan-
isms underlying the production of gaseous metabolites relevant to
these diseases.4. Clinical insight into the study of orofacial pain
Allodynia and/or hyperalgesia frequently occur in the orofacial
region following trigeminal nerve injury or orofacial inﬂammation
[36]. Pathological pain associated with such an injury/inﬂamma-
tion is severe and difﬁcult to treat, and occurs in wide areas
innervated by the injured as well as uninjured nerve ﬁbers. Similar
symptoms have been observed in uninﬂamed as well as inﬂamed
areas [37]. It is very important to understand the mechanisms
underlying extraterritorial orofacial pain associated with trigem-
inal nerve injury or orofacial inﬂammation in order to develop
appropriate measures for the treatment of patients with extra-
territorial orofacial pain. Sugimoto and colleagues described recent
ﬁndings in animal models, and the future directions of investiga-
tions of pathological pain mechanisms in their review article [38].
They summarized the current understanding of orofacial pain
mechanisms as follows: (1) neurotransmitters are released from
the somata of trigeminal ganglion (TG) neurons involved in per-
ipheral sensitization; (2) the neurotransmitters released from the
TG neurons are depressed after botulinum toxin-type A (BoNT/A)
administration, suggesting that BoNT/A decreases neuro-
transmitter release to reduce neuropathic pain behavior; (3) glial
cells are involved in the orofacial pathological pain associated with
trigeminal nerve injury or orofacial inﬂammation along with the
trigeminal spinal subnucleus caudalis and C1–C2 nociceptive
neurons; (4) the trigeminal sensory nuclear complex, especially
the trigeminal spinal subnucleus oralis, is structurally and func-
tionally involved in orofacial pain sensations in normal and
pathological pain conditions after peripheral nerve injuries;
(5) neuroimaging analyses have suggested functional changes in
the central and peripheral nervous systems in neuropathic pain
conditions.5. Carving a disease by omics
The CCN family is a group of matricellular proteins with six
distinct members in mammals; of these, CCN2 is required for the
proper development of the olfactory central nervous system [39],
pancreas [40], hair follicles [41], and skeletal system [42] and is
involved in multiple steps of orofacial development [43,44]. Spe-
ciﬁcally, CCN2 is important for skeletal development with the
support of complex gene regulatory systems in the relevant cells,
including osteoblasts, chondrocytes, and osteoclasts [42,45–47].
Kubota and colleagues focused on the biological roles of CCN2 in
different microenvironments in their review article [48]. Since the
proteins of the CCN family perform their functions through the
manipulation of multiple molecular counterparts in the micro-
environment, via molecular networks, the biological outcomes
yielded by these proteins are sometimes unpredictable. Through
combinatory investigation with metabolomic and transcriptomic
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by enhancing the glycolytic production of ATP via the enolase
1 gene. Further trans-omic approaches such as interactomics are
needed to identify and characterize more CCN2 molecular coun-
terparts that would help obtain a comprehensive understanding of
CCN2 functionality. Furthermore, this may lead to the discovery of
novel functional aspects of this unique extracellular signaling
modulator. The ﬁndings regarding the tissue regeneration poten-
tial and the critical role of CCN2 in ﬁbrotic remodeling in a variety
of tissues would be beneﬁcial in establishing new CCN2-mediated
therapeutics in clinical medicine and dentistry.6. The front line of bioimaging—new light shining on oral
biosciences
Fluorescent molecular imaging can be used to visualize biolo-
gical processes in live cells, tissues, and animals. This method
enables characterization of the localization and dynamics of par-
ticular molecules at the cellular and subcellular levels, and has
become an indispensable technique for understanding many bio-
logical processes [49–51]. Molecular biology-based engineering of
ﬂuorescent proteins (FPs) has allowed researchers to design and
create a variety of ﬂuorescent indicators capable of detecting ions,
intracellular messengers, phosphorylation, cell cycle stages, cell
death, and other molecules or events [49–54]. Tanimura, in his
review article [55] based on his ﬁndings [56,57], focused on FP-
based ﬂuorescent indicators that detect the concentration of
intracellular messenger molecules. The development of sophisti-
cated light microscopy techniques and ﬂuorescent indicators has
allowed for the visualization of dynamic processes in living cells.
These imaging methods are particularly suitable for studying Ca2þ
signaling, and have contributed to the discovery of spatially and
temporally organized responses such as Ca2þ waves and oscilla-
tions [58]. FP-based indicators enable the monitoring of intracel-
lular signaling, enzyme activities, apoptosis, cell cycle develop-
ment, and other cellular processes. These indicators are delivered
to the target cells or tissues as genetic material and are subse-
quently produced by the cells, either transiently or stably. Hence,
they are suitable for long-term experiments, both in vitro and
in vivo. This advantage of FP-based indicators extends their
application and contributes to understanding the functions of
particular molecules and cellular events during physiological
responses in live animals.
Osteocytes are the most predominant cells in the bone and are
located inside the mineralized bone matrix. Their cytoplasmic
processes form a complex intercellular network via gap junctions,
suggesting that osteocytes are the principal cells responsible for
sensing mechanical stimuli and transporting signals that coordi-
nate the adaptive bone-remodeling response [59]. Although
mechanical loading-induced matrix strain is thought to cause a
ﬂow of interstitial ﬂuid around the osteocyte processes [60,61], the
mechanism by which this ﬂuid ﬂow excites the osteocytes remains
unclear. Therefore, it is quite important to obtain precise mor-
phological and/or morphometrical data from osteocytes and their
surrounding matrix. In his review article [62] based on their
ﬁndings [63–65], Kamioka and colleagues introduced the appli-
cation of confocal laser scanning microscopy [66] to characterize
the osteocyte network in the bone. They also described a high-
resolution analysis of osteocyte morphology via ultra-high voltage
electron microscopy (UHVEM) [67]. Finally, they demonstrated
how the ﬂuid ﬂow causes ﬂuid shear stress around the osteocyte
processes using computer simulation based on a three-
dimensional nanoscale model of osteocyte canaliculi. They visua-
lized the entire osteocyte network in the bone as well as the
microstructure of osteocyte cell processes and the surroundingbone matrix and found that the ﬂuorescent analysis is useful for
studying the osteocyte network morphology. Furthermore, using a
three-dimensional image-based model of two distinct canaliculi,
they found that the microscopic surface roughness of the canali-
cular wall strongly inﬂuenced the proﬁle of the mechanical
loading-induced ﬂow of interstitial ﬂuid, whereby highly inho-
mogeneous ﬂow patterns emerged. These inhomogeneous ﬂow
patterns may induce the deformation of cytoskeletal elements in
the osteocyte processes, thereby amplifying mechanical signals.
Tooth germs develop via epithelial–mesenchymal interactions,
and the molecular mechanisms regulating this process have been
elucidated in various studies. Several conserved signaling mole-
cules have been implicated in the mediation of the epithelial–
mesenchymal interactions that regulate morphogenesis and cell
differentiation in tooth development. These molecules include
ﬁbroblast growth factors (FGFs), BMPs, Wnts, sonic hedgehog
(Shh), and Notch [68]. There is a wealth of data on the expression
patterns and functions of developmental regulatory molecules
(See http://bite-it.helsinki.ﬁ/). However, previous studies have not
focused on direct observation of cell dynamics, and none has
directly observed cell movement in the tooth germ. An organ
culture system for tooth development had been designed, and
two-photon laser microscopes have been used to observe cell
division and cell fate. Although there is no universally accepted
technique for observing cell fate at present, imaging has increased
our understanding of tooth organogenesis and would contribute to
the future elucidation of the mechanisms involved. Harada and
colleagues discussed the beneﬁts and limitations of live cell ima-
ging with respect to previous studies in their review article [69].
Although time-lapse imaging is a strong tool for understanding
cell movement and cell lineages, it is necessary to create a live
imaging system for effective observation of cell dynamics to elu-
cidate the mechanisms regulating tooth development.
The major salivary glands of humans and other mammals,
including the parotid gland (PG), submandibular gland (SMG), and
sublingual gland (SLG), are exocrine organs that secrete ﬂuids,
electrolytes, and proteins into the oral cavity. These glands are
comprised predominantly of two epithelial cell types, acinar and
ductal cells [70]. Salivary secretion is regulated primarily by the
sympathetic and parasympathetic nervous systems [71]. Para-
sympathetic stimulation induces ﬂuid and electrolyte secretion
through the activation of muscarinic acetylcholine receptors
(mAChRs) on salivary acinar cells. This activation is linked to the
breakdown of phosphoinositide, which in turn induces inositol
1,4,5-trisphosphate (IP3)-mediated Ca2þ release from intracellular
Ca2þ stores, followed by Ca2þ inﬂux across the plasma membrane.
The mechanism of Ca2þ signaling in salivary gland cells was
extensively examined using in vitro experiments employing
organic ﬂuorescent Ca2þ indicators, such as Fura-2 [72]. In parti-
cular, live cell Ca2þ imaging of salivary acinar cells revealed spa-
tiotemporal changes in calcium ion concentration ([Ca2þ]i),
including Ca2þ waves and Ca2þ oscillations. Recent advances in
imaging technologies, including ﬂuorescent microscopy and the
development of highly sensitive genetically encoded Ca2þ indi-
cators (GECIs), have enabled the visualization of Ca2þ responses in
live animals through intravital Ca2þ imaging in salivary acinar
cells [73]. In their review article [74] based on their ﬁndings
[75,76], Nezu and colleagues summarize in vitro studies of Ca2þ
responses in salivary acinar cells. In addition, they described an
intravital Ca2þ imaging method that enabled them to analyze the
role of Ca2þ responses in salivary gland function in live animals. To
examine the relationship between Ca2þ responses and salivary
secretion in vivo, they developed an intravital imaging method to
monitor Ca2þ responses in SMG acinar cells in vivo and success-
fully visualized agonist-induced increases in [Ca2þ]i in SMG acinar
cells in live animals. This novel experimental system allowed them
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animals and could be a powerful tool for elucidating the rela-
tionship between Ca2þ responses and salivary secretion induced
by various agonizts and the autonomic nervous system in vivo.
Fluorescence imaging represents a considerable breakthrough
in biomedical science by facilitating new ways of observing
molecular and cellular functions [77,78]. Although ﬂuorescence
imaging is widely used as a tool to conﬁrm research hypotheses by
high-resolution and colorful images, the technology is advanta-
geous in that quantitative data can also be derived from the
acquired images. Histological analysis has long been a powerful
and informative approach, providing spatial information in tis-
sues; however, such analyses often lack quantitative information.
Fluorescence imaging with quantitative analysis is considered a
suitable method for spatial and temporal data collection, as well as
for functional quantiﬁcation. In their review article [79] based on
their ﬁndings [80,81], Lee and Iimura introduced the general
methodology of quantitative ﬂuorescence imaging and discussed
its applications by reviewing their recent ﬁndings in osteocyte
function. Quantitative ﬂuorescence imaging is undoubtedly a
powerful approach to uncover unprecedented biomedical phe-
nomena. To exclude misinterpretation and subjective deductions
from imaging data, multiple approaches and multimodality will be
increasingly emphasized. Image processing and mathematical
analyses would play an important role in providing further critical
information, especially in vivo experiments.7. Biodental engineering—integration of biology and material
science
As a complimentary approach, biologists have begun to engi-
neer biological materials themselves, including genes, molecules,
cells, and tissues [82–85]. Induced pluripotent stem (iPS) cells may
provide insights into the most basic questions within the ﬁeld of
cell differentiation, and into the capabilities of iPS cells in mole-
cular and cellular biology [86,87]. iPS cells have also been reported
to have potential clinical applications for the treatment of many
diseases, particularly in the ﬁelds of regenerative medicine and
tissue engineering [88–90]. Thus, the emergence of new research
ﬁelds bridging engineering and biology is expected to provide a
more comprehensive understanding of basic biology, as well as
advancements in technological applications. In dentistry, the new
ﬁeld of biodental engineering integrates the sciences of dentistry
and engineering. In their review article [91], Matsumoto and col-
leagues highlighted and discussed four examples of biodental
engineering applications and advancements. Egusa and colleagues
demonstrated that gingival ﬁbroblasts (GFs), easily obtained from
gingival tissues, can be readily reprogrammed into iPS cells
without Myc transduction or a speciﬁc system for the selection of
successfully reprogrammed cells, thus making them a promising
source of cells for investigating the basis of cellular reprogram-
ming and pluripotency for future clinical applications [92,93] to
lead a variety of potential uses for both biological and treatment
outputs. Kato and colleagues have focused on the speciﬁc
expression patterns of cell surface markers to characterize stem
cell populations. For this purpose, they have developed special
material surfaces onto which multiple antibodies speciﬁc for sur-
face markers were immobilized in an array format [94,95]. This
can lead to the development of valuable tools for obtaining
information on different aspects of stem cell populations. Tsuji and
colleagues proposed a third technique, termed the three-
dimensional organ-germ culture method. With this technique,
they generated a tooth with the correct structure, using both
in vitro organ culture and transplantation into an alveolar socket
in vivo [96–98]. This study provides important insights into howcells self-assemble and function during tooth and salivary gland
development. Matsumoto and colleagues also fabricated a large
three-dimensional (3D) mesenchymal stem-cell (MSC) construct
with a ball-like morphology (which they termed a cell ball), and
cultured this 3D cell ball under hypoxic conditions, which causes
chondrogenic differentiation of MSCs in primordial cartilage, a
process that is crucial for ossiﬁcation [99,100]. In the last half-
century, biologists had begun to isolate themselves from
researchers in other scientiﬁc ﬁelds. This so-called reductionist
approach to biology is now being replaced with a more compre-
hensive, integrated approach, and researchers in biomedical ﬁelds
are collaborating with other scientists in chemistry, engineering,
materials science, and physics to develop new approaches to
address old problems. Such is the case in the emerging ﬁeld of
biodental engineering, which combines biological sciences, engi-
neering, and dentistry to develop methods, techniques, and tech-
nologies for both basic and applied sciences. Advancements in this
ﬁeld would provide new therapeutic approaches for improving the
quality of life of dental patients.8. Translational dental research over the CCN family
Matrix metalloproteases (MMPs) are generally thought to be
involved in the degradation of extracellular matrix (ECM) com-
ponents in the dental pulp. Interestingly, some MMPs, including
MMP-2, MMP-3, MMP-9, and MMP-13, were also shown to be
internalized by cells [101–104]. CCN family member 2/connective
tissue growth factor (CCN2/CTGF) is a secretory protein belonging
to the CCN family. CCN2/CTGF is a well-known osteogenesis- and
chondrogenesis-related protein necessary for tooth development
[105,106]. A previous report showed that CCN2/CTGF plays a role
in the MMP-3-induced migration of human dental pulp cells, and
the endocytosis-related protein dynamin mediates MMP-3-
induced CCN2/CTGF expression [107]. Furthermore, bone mor-
phogenetic protein (BMP)-1 participates in reparative dentino-
genesis via CCN2/CTGF expression, and both MMP-3 and BMP-1
are shown to induce these effects independent of the protease
activity. Therefore, the role of metalloproteases is not limited to
catalytic enzyme activity during ECM remodeling; it also includes
dental pulp repair. In the latter process, CCN2/CTGF is implicated
as a key factor. In their review article [108], Muromachi and col-
leagues focused on novel roles of metalloproteases, speciﬁcally
MMP-3 and BMP-1, and discuss the action of CCN2/CTGF in den-
tin–pulp complex repair. The classical role of metalloproteases as
catalytic enzymes has recently been expanded to include their
novel function as signaling molecules. However, it remains to be
determined which cell surface molecules interact with MMP-3 and
BMP-1. Further research on the relationship between metallopro-
teases and CCN2/CTGF expression would help shed light on their
role in dentin–pulp complex regeneration and repair.9. Salivary glands
Vacuolar Hþ-ATPase (V-ATPase) is localized in the membranes
of intracellular organelles such as vacuoles, lysosomes, the Golgi
apparatus, and synaptic vesicles. Intracellular V-ATPase is impor-
tant for membrane trafﬁcking processes, including receptor-
mediated endocytosis, protein processing and degradation, and
the coupled transport of small molecules such as neuro-
transmitters [109]. V-ATPase is also expressed in plasma mem-
branes, contributing to proton transport across the membrane of
specialized cells, and acidifying adjacent lumina or interstitial
spaces in some organs [110,111]. The functional role of V-ATPase
remains unknown in the salivary gland [112]. The present review
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especially the cellular location of V-ATPase and its role in luminal
acidiﬁcation [113]. In addition, how acidiﬁcation is regulated in the
salivary glands was discussed by referring to the mechanism in the
pancreatic duct, or collecting duct of the kidney. Advances in the
phenotypic analysis of increasing numbers of mutants have helped
gain an overview of the biological and physiological signiﬁcance of
individual subunits [114,115]. Although redundancies, compensa-
tory mechanisms, and adaptive responses can occur, null mice of
several subunit isoforms will be useful in better understanding
their functions [116]. Studies deﬁning the role of V-ATPase in the
salivary ducts await conﬁrmation of its presence at this site.
Accumulating physiological knowledge, together with structural
studies and progressive clinical experiments, could provide new
insights and a signiﬁcantly better understanding of the mechan-
ism of action of V-ATPase and its vital contribution to life and
health.10. Break the negative spiral consisting of periodontitis, dia-
betes and Alzheimer's disease: extending healthy life expec-
tancy through oral health
An estimated 36 million people worldwide have Alzheimer's
disease (AD) or related dementias. The development of treatments
that delay the onset of AD by ﬁve years is estimated to potentially
reduce the number of AD patients by half. Recently, considerable
attention has been focused on lifestyle related diseases, including
diabetes [117] and periodontitis [118–121], as exacerbating factors
for AD. Nakanishi and Wu focused on the strategies to prevent AD
progression in their review article [122]. Low-grade chronic sys-
temic inﬂammatory signals associated with these diseases may
activate primed or senescent microglia, which subsequently pro-
voke an exaggerated neuroinﬂammation. Furthermore, the bidir-
ectional relationship between periodontitis and diabetes may
amplify chronic systemic inﬂammatory signals that contribute to
AD progression. Moreover, oral bacteria and their virulence factors
inﬁltrate the brain parenchyma, provoking neuroinﬂammation.
These observations indicate that periodontitis and diabetes pro-
mote AD progression. Furthermore, activation of the oral sensory
system during mastication is a well-established contributor to
brain health. Conversely, orofacial pain reduces the quality of life
and contributes to both eating disorders and malnutrition in
elderly people. Therefore, oral brain science strategies should be
established for extending healthy life expectancy through brain
health, which originates from oral health.11. Immunology and oncology
During the past two decades, the notion that inﬂammatory
events can promote cancer growth has experienced a vigorous
renaissance, fueled by the development of new animal models of
cancer, and rapid advances in the ﬁelds of immunology and
inﬂammation [123–125]. These discoveries have led to a model
positing that inﬂammation acts as a facilitator of cancer growth. In
their review article [126], Postler and Ghosh focused on the
molecules that have been linked to various cancers. Two classes of
cellular regulators have emerged as particularly dominant players:
the Ras family of small guanosine triphosphatases (GTPases),
members of which are mutated in human solid cancers more
frequently than any other type of gene, and the NF-κB family of
transcription factors, which are the central regulators of inﬂam-
mation and growth. Ras and NF-κB signaling are involved in such a
breadth of biological processes that any broad-acting inhibition of
either or both pathways is likely to have severe systemic sideeffects and thus be unsuitable as chronic treatment for long-term
illnesses, such as cancer or chronic inﬂammation. Therefore, tar-
geted intervention at the level of more speciﬁc modulators of
signaling offers a more appealing strategy than shutting down the
entire pathway. For instance, overexpression of κB-Ras proteins
does not abrogate NF-κB signaling completely but modiﬁes the
expression of a subset of IκB-β-dependent target genes [127–129].
Similarly, overexpression of κB-Ras does not eliminate Ras sig-
naling but acts speciﬁcally on the Ral pathway, which is essential
for anchorage-independent proliferation, while leaving PI3K-
dependent signaling intact [127,130–132]. Nonetheless, the
expression of κB-Ras proteins is sufﬁcient to signiﬁcantly reduce
the growth of tumor cells [127]. Thus, therapeutic intervention
focusing on speciﬁc modulators of signaling may open up effective
but safe new approaches to chemotherapy.12. Oral microbiome and bioﬁlm research: new concepts and
new approaches
Xerostomia is a clinical condition caused by dry oral mucosa, or
a reduction or absence of salivary ﬂow. The estimated worldwide
prevalence of xerostomia among elderly individuals (over 65 years
old) is approximately 30% [133]. It has been reported that xer-
ostomia is caused by radiotherapy for head and neck cancer,
Sjögren's syndrome, poor glycemic control in diabetes, or obesity
[134–137]. Thus, a precise understanding of the qualitative
alterations of the oral microbiota caused by dry mouth, and
appropriate oral care should help prevent caries and candidiasis;
consequently, the prophylaxis of oral diseases would contribute to
improve quality of life (QOL) in the elderly. In their review article
[138] based on their ﬁndings [139], Hayashi and colleagues have
discussed hyposalivation, clinical ﬁndings, and qualitative altera-
tions of the oral microbiota, in order to prevent oral diseases
caused by dry mouth. Using culturing of the microbiota and
molecular biological assessment of 16S rDNA to evaluate the
relationship between saliva secretion and the oral microbiota, they
showed that hyposalivation contributes not only to ﬂuctuations in
the numbers of certain microorganisms, but also inﬂuences the
composition of the microbiota (the microbial ecosystem) in the
oral cavity. Furthermore, Candida sp., which prefers a dry envir-
onment, appears to increase and replace the normal ﬂora under
such conditions. Such alterations are reﬂected by clinical indices,
such as the number of decayed teeth, decayed, missing, or ﬁlled
Teeth (DMFT), and the prevalence rate of candidiasis in the clinical
studies. Hyposalivation may not be directly related to the onset of
periodontal disease. It is reasonable to assume that hyposalivation
is an indirect risk factor for the progression of periodontal disease
due to the higher supragingival plaque index associated with
lower levels of saliva. In order to treat health concerns associated
with hyposalivation (mastication disorder, anorexia, dysphagia,
oral mucosal inﬂammation, risk of caries, and periodontal dis-
eases), more attention should be paid to global alterations of the
microbiota and prophylaxis of oral diseases.13. Bone remodeling mechanisms of bone resorption and
bone formation
BMPs induce ectopic bone formation when implanted into
muscle tissue and stimulate osteoblast differentiation of various
cell types [140,141]. BMP signaling is transduced by two types of
transmembrane serine/threonine kinase receptors, namely, type I
and II receptors [142,143]. SMAD signaling plays a central role
among the downstream effectors of BMP receptors and plays an
important role in osteoblast differentiation [144]. Both Osterix and
Editorial / Journal of Oral Biosciences (2016) 1–96RUNX2 are essential factors for osteoblast differentiation, and their
expression is activated by the BMP-SMAD signaling pathway
[145,146]. BMP signaling and BMP-induced osteoblast differ-
entiation are negatively regulated at each step by various factors.
In their review article [147] based on their ﬁndings [148–150],
Kokabu and colleagues focused on BMP signaling and its inhibitory
mechanisms during osteoblast differentiation. In addition, they
discussed strategies for treating bone-related diseases such as
osteoporosis as well as for the tissue engineering of the bone by
using BMPs. BMP signaling and its regulators were introduced,
with a special emphasis on inhibitory factors. Reducing the activity
or expression of these inhibitory factors could be useful for
increasing endogenous BMP signaling. Developing methods of
releasing these inhibitory mechanisms may shed light on novel
bone formation therapies.14. The front line of oral bioﬁlm research
From birth, the infant is exposed to and colonized by a wide
range of microorganisms, derived mainly from the mother. The
biological properties of each habitat determine which micro-
organisms can colonize and grow, and determine the major and
minor components of the resident microbiota of a site. This results
in different surfaces having distinct but characteristic microbiotas
[151–155]. In their natural environment, microorganisms revert to
their so-called ‘bioﬁlm phenotype’, and down-regulate certain
activities and up-regulate the production of polymeric substances
that act as viscoelastic inter-cellular binding material and extra-
cellular energy storage compounds, amongst other roles [156,157].
This mode of existence offers protection against external stresses
and promotes interactions among neighboring microbial cells
[158], as well as between the bioﬁlm and the host, resulting in a
complex and dynamic interplay. In their review article [159] based
on their ﬁndings [160–162], Marsh and colleagues focused on the
oral microbiota that provides major beneﬁts to the host including:
(a) colonization resistance, (b) down-regulation of potentially
damaging host inﬂammatory responses, and (c) active contribu-
tions to the normal development of the physiology of the mouth
and the host defenses. The oral microbiota is natural and beneﬁcial
to the host, and disease is associated with shifts in the balance of
the normal resident microbiota. In this way, dental diseases
represent examples of (minor) ecological catastrophes, in which
the oral microbiota is disrupted in response to a change in the
local environment [163]. This has implications for treatment, and
opens up potentially new avenues to control or prevent disease.
Therefore, when a patient presents with a dental disease, a clin-
ician should attempt to determine the factors responsible for
driving dysbiosis, while recognizing that these could vary from
patient to patient. These factors could include impaired saliva ﬂow,
poor oral hygiene techniques, inappropriate lifestyle, poor dietary
habits, an impaired immune system, or the presence of other risk
factors. Unless there is an attempt to interfere with or alter the
factor(s) driving the dysbiosis, the patient is likely to keep
returning to the surgery suffering from further episodes of the
disease. An appreciation of the ecological principles may lead to
opportunities in the future to manipulate the composition and
metabolism of the oral microbiota in order to maintain the beneﬁt
we derive from their presence and activity, while minimizing the
impact of any environmental and lifestyle factors that might lead
to dysbiosis.
15. Microbiology
The bacterial etiology of chronic periodontitis is acknowledged
to be polymicrobial in nature. There is a consensus that theanaerobic, proteolytic, amino acid-fermenting species Porphyr-
omonas gingivalis plays a signiﬁcant role in either initiation or
progression of the disease [164–167]. Based on animal model data,
P. gingivalis has recently been proposed to be a “keystone patho-
gen” that manipulates the host response to favor the proliferation
of a pathogenic polymicrobial bioﬁlm (dysbiosis) and the devel-
opment of the disease [166]. A previous report demonstrated in a
longitudinal human study that the imminent progression of
chronic periodontitis could be predicted by increases in the rela-
tive levels of P. gingivalis and/or Treponema denticola in subgingival
plaque [168], which is consistent with other clinical studies
demonstrating that P. gingivalis levels in subgingival plaque are
predictive of human disease progression [169–171]. P. gingivalis is
also capable of causing periodontitis in animal models of the
disease [172,173]. Reynolds and colleagues focused on the ﬁnding
that P. gingivalis has novel heme, iron, and manganese transporters
and metalloregulatory proteins that enable it to switch rapidly
between an energy-efﬁcient iron-dependent virulent phase and a
protective manganese-dependent survival phase in their review
article [174]. The clear interplay between iron, manganese, heme,
and oxidative stress protection may enable the anaerobic P. gin-
givalis to maintain a high level of intracellular ferrous iron to
maximize growth and virulence using energy-efﬁcient iron-
dependent metabolism, and to rapidly replace this potentially
deadly metal with manganese for survival during oxidative stress
by switching to a more protective, but much more restrictive,
manganese-based physiology.Conﬂict of interest
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